Skip to main content
. Author manuscript; available in PMC: 2007 Mar 31.
Published in final edited form as: Biochem Biophys Res Commun. 2006 Feb 3;342(1):50–56. doi: 10.1016/j.bbrc.2006.01.122

Fig. 4.

Fig. 4

Partial stabilization of IRF7 by IFN treatment of thymocytes and splenocytes. IRF7 and IRF3 half-lives were measured in thymocytes (A) and splenocytes (B) as described in Fig. 2, except cells were pretreated overnight with IFN prior to CHX treatment.

HHS Vulnerability Disclosure